HAEMOPHILIA B
Clinical trials for HAEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA B trials appear
Sign up with your email to follow new studies for HAEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young boys with rare bleeding disorder
Disease control CompletedThis trial tested a new, long-acting version of a missing clotting protein (Factor IX) in young boys with severe hemophilia B who had little to no prior treatment. The goal was to see if regular injections could safely prevent bleeding episodes and effectively treat bleeds when t…
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Real-World safety check for hemophilia treatment
Disease control CompletedThis study monitored the safety and effectiveness of Refixia, a treatment for Hemophilia B, during routine medical care in Japan. Researchers followed 28 patients who were already prescribed Refixia by their doctors to track side effects and see how well the treatment controlled …
Matched conditions: HAEMOPHILIA B
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with rare bleeding disorder
Disease control CompletedThis trial tested a new, long-acting medication (N9-GP) to control bleeding in children with severe hemophilia B. It involved 25 boys under 13 who had previously used other treatments. The main goals were to see if the drug was safe, how well it prevented and treated bleeds, and …
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for hemophilia b patients in china: Long-Lasting treatment shows promise
Disease control CompletedThis study tested how well a long-acting medicine called nonacog beta pegol works to prevent and treat bleeding episodes in Chinese men and boys with hemophilia B. Thirty participants received the medicine by injection for about a year to see how well it controlled bleeds and how…
Matched conditions: HAEMOPHILIA B
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC